Sanofi’s Inozyme Pharma INZY Stock Holding History

Sanofi’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-443,255	Closed	-$1.77M	–	11
2025 Q2	$1.77M	Hold	443,255	–	–	1.01%	8
2025 Q1	$403K	Hold	443,255	–	–	0.24%	8
2024 Q4	$1.23M	Buy	+443,255	New	+$1.69M	0.7%	8

Sanofi's INZY Position: Q3 2025 in Review

Sanofi sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 443,255 shares — an estimated $1.77M sold.

Sanofi first reported a position in INZY in Q4 2024 and held it in 3 quarters. The position peaked at $1.77M in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Sanofi reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Sanofi sold 443,255 Inozyme Pharma shares in Q3 2025, an estimated $1.77M.
Sanofi first reported a position in Inozyme Pharma in Q4 2024 and held it in 3 quarters.
Sanofi's Inozyme Pharma position peaked at $1.77M in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Sanofi's 13F filing for Q3 2025, filed 4 Nov 2025.